AI in Clinical Trials Market Forecast to Reach USD 7.32 Billion by 2034

Maximize Market Research said in a press release that the global AI in clinical trials market was valued at USD 2 billion in 2025 and could reach USD 7.32 billion by 2034. The forecast represents a compound annual growth rate of 15.5% from 2026 to 2034.

AI applications covered by the report include patient recruitment, cohort selection, trial design, clinical data analysis, safety monitoring, drug discovery, personalized medicine, patient monitoring, and treatment optimization. The report examines machine learning, natural language processing, and deep learning across Phase I, Phase II, and Phase III trials.

North America currently leads the market, while adoption is also growing in Europe and the Asia Pacific region. The report identifies data privacy, regulatory compliance, data quality, transparency, reliability, and a shortage of specialized AI expertise as constraints on adoption.